| Literature DB >> 33004969 |
Agnes Napyo1,2,3, Victoria Nankabirwa4,5, David Mukunya5, Josephine Tumuhamye5, Grace Ndeezi6, Anna Agnes Ojok Arach6,7, Beatrice Odongkara6,5,8, Paul Waako9, Thorkild Tylleskär5, James K Tumwine6.
Abstract
Prevention of unintended pregnancies is a global strategy to eliminate mother-to-child transmission of HIV. Factors surrounding unintended pregnancy among women living with HIV are not well understood. We aimed to determine the prevalence and predictors for unintended pregnancy among these women in Northern Uganda. We conducted a cross-sectional survey among 518 women using a structured questionnaire. We asked questions on socio-demographic, reproductive-related and HIV-related characteristics. We conducted multivariable logistic regression and reported adjusted odds ratios. The prevalence of unintended pregnancy was 41.1%. The predictors for unintended pregnancy were: being single (not living with a partner or being in a marital union), having five or more children and taking antiretroviral drugs for long periods of time. HIV counselling services should target women living with HIV who are not in a marital union, those having a higher parity and those who have taken ART for longer periods.Entities:
Mesh:
Year: 2020 PMID: 33004969 PMCID: PMC7529765 DOI: 10.1038/s41598-020-73490-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flow diagram illustrating rationale for screening, enrolment and non-enrolment.
Baseline demographic characteristics of HIV infected pregnant women receiving antenatal care at Lira Regional Referral Hospital.
| Characteristics | Total | Pregnancy intended | Pregnancy not intended |
|---|---|---|---|
| (N = 518) | (N = 305) | (N = 213) | |
| n (%) | n (%) | n (%) | |
| ≤ 20 years | 35 (6.8) | 23 (7.5) | 12 (5.6) |
| 21–29 years | 229(44.2) | 150 (49.2) | 79 (37.1) |
| ≥ 30 years | 254 (49.0) | 132 (43.3) | 122 (57.3) |
| 0–6 years | 268 (51.7) | 143 (46.9) | 125 (58.7) |
| 7–10 years | 171 (33) | 105 (34.4) | 66 (31) |
| 11–13 years | 51 (9.9) | 35 (11.5) | 16 (7.5) |
| ≥ 14 years | 28 (5.4) | 22 (7.2) | 6 (2.8) |
| Married | 484 (93.4) | 295 (96.7) | 189 (88.7) |
| Single | 34 (6.6) | 10 (3.3) | 24 (11.3) |
| Employed | 207 (40) | 129 (42.3) | 78 (36.6) |
| Not employed | 311 (60) | 176 (57.7) | 135 (63.4) |
| Christian | 500 (96.5) | 292 (95.7) | 208 (97.7) |
| Moslem | 18 (3.5) | 13 (4.3) | 5 (2.3) |
| Langi | 472 (91.1) | 275 (90.2) | 197 (92.5) |
| Other | 46 (8.9) | 30 (9.8) | 16 (7.5) |
| Group 1 (poorest) | 139 (26.8) | 80 (26.2) | 59 (27.7) |
| Group 2 | 122 (23.6) | 69 (22.6) | 53 (24.9) |
| Group 3 | 170 (32.8) | 96 (31.5) | 74 (34.7) |
| Group 4 (least poor) | 87 (16.8) | 60 (19.7) | 27 (12.7) |
Other characteristics.
| Characteristics | Total | Pregnancy intended | Pregnancy not intended |
|---|---|---|---|
| (N = 518) | (N = 305) | (N = 213) | |
| n (%) | n (%) | n (%) | |
| ≤ 4 | 375 (72.4) | 247 (81.0) | 128 (60) |
| ≥ 5 | 143 (27.6) | 58 (19.0) | 85 (40) |
| 20–27 | 279 (53.9) | 165 (54.1) | 114 (53.5) |
| 28–35 | 171 (33) | 102 (33.4) | 69 (32.4) |
| ≥ 36 | 68 (13.1) | 30 (12.5) | 30 (14.1) |
| Not accompanied | 465 (89.8) | 272 (89.2) | 193 (90.6) |
| Accompanied on day of interview | 53 (10.2) | 33 (10.8) | 20 (9.4) |
| Did not use | 258 (49.8) | 163 (53.4) | 95 (44.6) |
| Used 6 months prior to pregnancy | 260 (50.2) | 142 (46.6) | 118 (55.4) |
| None or safe days | 267 (51.5) | 167 (54.8) | 100 (47) |
| Effective contraception | 251 (48.5) | 138 (45.2) | 113 (53) |
| Disclosed | 501 (96.7) | 299 (98.0) | 202 (94.8) |
| Not disclosed | 17 (3.3) | 6 (2.0) | 11 (5.2) |
| Husband | 398 (76.8) | 244 (80.0) | 154 (72.3) |
| Other | 120 (23.2) | 61 (20.0) | 59 (27.7) |
| Had no fear | 253 (48.8) | 139 (45.6) | 114 (53.5) |
| Had fear | 265 (51.2) | 166 (54.4) | 99 (46.5) |
| Efavirenz-based | 466 (90) | 279 (91.5) | 187 (87.8) |
| Nevirapine-based | 44 (8.5) | 23 (7.5) | 21 (9.9) |
| Protease inhibitor–based | 8 (1.5) | 3 (0.1) | 5 (2.4) |
| Less than 6 months | 98 (18.9) | 64 (21) | 34 (16) |
| 7 to 30 months | 117 (22.6) | 70 (23) | 47 (22) |
| 31 to 119 months | 267 (51.5) | 159 (52.1) | 108 (50.7) |
| ≥ 120 months | 36 (7) | 12 (3.9) | 24 (11.3) |
Predictors for unintended pregnancy among HIV infected women in Northern Uganda.
| Variables | Crude OR | Adjusted OR | Adjusted OR | |||
|---|---|---|---|---|---|---|
| (95% CI) | (95% CI)a | (95% CI)b | ||||
| ≤ 20 years | 0.56 (0.27–1.18) | 0.13 | 0.74 (0.3–1.81) | 0.505 | – | – |
| 21–29 years | 0.57 (0.39–0.82) | 0.003 | 0.86 (0.55–1.34) | 0.501 | – | – |
| ≥ 30 years | 1 | 1 | – | – | ||
| 0–6 years | 1 | 1 | – | – | ||
| 7–10 years | 0.72 (0.49–1.06) | 0.098 | 0.88 (0.57–1.36) | 0.563 | – | – |
| 11–13 years | 0.52 (0.28–0.99) | 0.047 | 0.71 (0.35–1.44) | 0.345 | – | – |
| ≥ 14 years | 0.31 (0.12–0.79) | 0.015 | 0.5 (0.18–1.37) | 0.176 | – | – |
| Married | 1 | 1 | 1 | |||
| Single | 3.75 (1.75–8) | 0.01 | 3.81 (1.68–8.66) | 0.001 | 0.001 | |
| Employed | 1 | 1 | – | – | ||
| Not employed | 1.27 (0.89–1.81) | 0.195 | 1.13 (0.74–1.73) | 0.581 | – | – |
| ≤ 4 | 1 | 1 | 1 | |||
| ≥ 5 | 2.83 (1.9–4.2) | 0.000 | 2.4 (1.5–3.86) | 0.000 | 0.000 | |
| Disclosed | 1 | 1 | 1 | |||
| Not disclosed | 2.71 (0.99–7.46) | 0.053 | 2.55 (0.84–7.76) | 0.1 | 2.59 (0.86–7.78) | 0.09 |
| Group 1 (poorest) | 1 | 1 | – | – | ||
| Group 2 | 1.04 (0.64–1.70) | 0.871 | 1.25 (0.73–2.14) | 0.425 | – | – |
| Group 3 | 1.05 (0.66–1.64) | 0.848 | 1.44 (0.87–2.38) | 0.16 | – | – |
| Group 4 (least poor) | 0.61 (0.35–1.07) | 0.087 | 0.91 (0.48–1.73) | 0.781 | – | – |
| None or safe days | 1 | 1 | 1 | |||
| Effective contraception | 1.37 (0.96–1.94) | 0.081 | 1.33 (0.9–1.96) | 0.148 | 1.34 (0.92–1.95) | 0.132 |
| Efavirenz-based | 1 | 1 | – | – | ||
| Nevirapine-based | 1.36 (0.73–2.53) | 0.328 | 0.93 (0.43–1.99) | 0.85 | – | – |
| Protease inhibitor-based | 2.49 (0.59–10.53) | 0.216 | 2.24 (0.4–12.41) | 0.356 | – | – |
| 0 to 6 months | 1 | 1 | 1 | |||
| 7 to 30 months | 1.26 (0.72–2.2) | 0.409 | 1.25 (0.68–2.3) | 0.482 | 1.29 (0.71–2.36) | 0.398 |
| 31 to 119 months | 1.28 (0.79–2.07) | 0.318 | 1.15 (0.66–2.01) | 0.628 | 1.19 (0.7–2.03) | 0.517 |
| ≥ 120 | 3.76 (1.68–8.45) | 0.001 | 3.32 (1.24–8.92) | 0.017 | 0.003 | |
The bold figures in Table 3 represent the significant predictors for unintended pregnancy.
aR2 = 0.0902.
bR2 = 0.0789.